320 related articles for article (PubMed ID: 7479679)
1. The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets.
Fehmann HC; Hering BJ; Wolf MJ; Brandhorst H; Brandhorst D; Bretzel RG; Federlin K; Göke B
Pancreas; 1995 Aug; 11(2):196-200. PubMed ID: 7479679
[TBL] [Abstract][Full Text] [Related]
2. Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development.
García-Flores M; Zueco JA; Alvarez E; Blázquez E
Eur J Biochem; 2001 Feb; 268(3):514-20. PubMed ID: 11168389
[TBL] [Abstract][Full Text] [Related]
3. Peptidergic regulation of maturation of the stimulus-secretion coupling in fetal islet beta cells.
Sjöholm A; Sandberg E; Ostenson CG; Efendić S
Pancreas; 2000 Apr; 20(3):282-9. PubMed ID: 10766455
[TBL] [Abstract][Full Text] [Related]
4. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
Qader SS; Håkanson R; Rehfeld JF; Lundquist I; Salehi A
Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
[TBL] [Abstract][Full Text] [Related]
5. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Farilla L; Bulotta A; Hirshberg B; Li Calzi S; Khoury N; Noushmehr H; Bertolotto C; Di Mario U; Harlan DM; Perfetti R
Endocrinology; 2003 Dec; 144(12):5149-58. PubMed ID: 12960095
[TBL] [Abstract][Full Text] [Related]
7. Functional receptors for the insulinotropic hormone glucagon-like peptide-I(7-37) on a somatostatin secreting cell line.
Fehmann HC; Habener JF
FEBS Lett; 1991 Feb; 279(2):335-40. PubMed ID: 1672112
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
9. Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells.
Fehmann HC; Janssen M; Göke B
Acta Diabetol; 1995 Oct; 32(3):176-81. PubMed ID: 8590787
[TBL] [Abstract][Full Text] [Related]
10. Effect of stimulators such as GLP-1, PACAP, and nicotinamide on glucose-stimulated insulin secretion from porcine pancreatic endocrine cells in long-term culture.
Sato A; Wang PC; Ohgawara H
Pancreas; 2002 Jul; 25(1):86-93. PubMed ID: 12131777
[TBL] [Abstract][Full Text] [Related]
11. Insulinotropic effects of cholecystokinin, gastric inhibitory polypeptide and glucagon-like peptide-1 during perifusion of short-term cultured canine isolated islets.
van der Burg MP; Guicherit OR; Frölich M; Gooszen HG
Regul Pept; 1995 Dec; 60(1):61-7. PubMed ID: 8747785
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of glucagon-like peptide 1 insulinotropic action by succinic acid dimethyl ester.
Leclercq-Meyer V; Malaisse WJ
Life Sci; 1996; 58(14):1195-9. PubMed ID: 8614271
[TBL] [Abstract][Full Text] [Related]
13. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
14. The structure-function relationship of GLP-1 related peptides in the endocrine function of the canine pancreas.
Ohneda A; Ohneda K; Ohneda M; Koizumi F; Ohashi S; Kawai K; Suzuki S
Tohoku J Exp Med; 1991 Nov; 165(3):209-21. PubMed ID: 1807008
[TBL] [Abstract][Full Text] [Related]
15. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
Heller RS; Aponte GW
Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
[TBL] [Abstract][Full Text] [Related]
16. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
Lam NT; Kieffer TJ
Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
[TBL] [Abstract][Full Text] [Related]
17. Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction.
Fehmann HC; Bode HP; Ebert T; Karl A; Göke B
Horm Metab Res; 1997 Nov; 29(11):572-6. PubMed ID: 9479558
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
Miura Y; Matsui H
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
D'Alessio DA; Fujimoto WY; Ensinck JW
Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol.
Zawalich WS; Zawalich KC
Metabolism; 1996 Feb; 45(2):273-8. PubMed ID: 8596502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]